
Green-Lipped Mussel Reduces Joint Pain and Inflammatory Bacteria
Results of a clinical trial on green-lipped mussel extract from Aroma New Zealand.
Researchers from the University of Queensland in Australia assigned 38 knee osteoarthritis sufferers to 3000 mg of glucosamine sulphate or green-lipped mussel extract daily for 12 weeks.
Compared to glucosamine, the green-lipped mussel extract resulted in better WOMAC and Lequesne pain scores, and a reduced use of painkillers during the study. Fecal microbial analysis indicated that both treatments improved bacteria profiles of the gut towards a less-inflammatory state.
In light of positive results Aroma NZ has witnessed with its branded ingredient, the company says it intends to apply for a joint health claim in the EU.
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





